AAAAAA

   
Results: 1-16 |
Results: 16
CISPLATIN CARBOPLATIN/CYCLOPHOSPHAMIDE (CCP) VS CISPLATIN/CYCLOPHOSPHAMIDE (CP) IN STAGE III-IV EPITHELIAL OVARIAN-CANCER - A FRENCH RANDOMIZED PHASE-III STUDY/
Authors: HERON JF JOLY F KERBRAT P CHAUVERGNE J MAYER F WEBER B CHINETCHARROT P CROUET H GOUPIL A LESECH JM LEBRUNJEZEKOVA D NAMER M MARTIN C GUASTALLA JP LHOMME C
Citation: Jf. Heron et al., CISPLATIN CARBOPLATIN/CYCLOPHOSPHAMIDE (CCP) VS CISPLATIN/CYCLOPHOSPHAMIDE (CP) IN STAGE III-IV EPITHELIAL OVARIAN-CANCER - A FRENCH RANDOMIZED PHASE-III STUDY/, Annals of oncology, 9, 1998, pp. 315-315
AN EORTC-ECSG PHASE-II STUDY OF VINORELBINE IN PATIENTS WITH RECURRENT AND OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK/
Authors: DEGARDIN M OLIVEIRA J GEOFFROIS L ROLLAND F ARMAND JP BASTIT P CHAUVERGNE J FARGEOT P VANGLABBEKE M LENTZ MA TRESCA P BOUDILLET J FUMOLEAU P CAPPELAERE P
Citation: M. Degardin et al., AN EORTC-ECSG PHASE-II STUDY OF VINORELBINE IN PATIENTS WITH RECURRENT AND OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK/, Annals of oncology, 9(10), 1998, pp. 1103-1107
ETHICS OF CLINICAL RESEARCH
Authors: HOERNI B BONICHON F CHAUVERGNE J
Citation: B. Hoerni et al., ETHICS OF CLINICAL RESEARCH, Bulletin du cancer, 85(1), 1998, pp. 98-101
RESULTS OF A PHASE-II TRIAL WITH CYSTEMUSTINE IN ADVANCED MALIGNANT-MELANOMA - A TRIAL OF THE EORTC CLINICAL SCREENING GROUP
Authors: UROSEVIC V CHOLLET P ADENIS A CHAUVERGNE J FARGEOT P ROCHE H KERBRAT P LENTZ MA FUMOLEAU P CHEVALLIER B
Citation: V. Urosevic et al., RESULTS OF A PHASE-II TRIAL WITH CYSTEMUSTINE IN ADVANCED MALIGNANT-MELANOMA - A TRIAL OF THE EORTC CLINICAL SCREENING GROUP, European journal of cancer, 32A(1), 1996, pp. 181-182
PREDICTIVE VALUE OF HEMATOLOGICAL COUNTS AT THE 4TH DAY AFTER CARBOPLATIN-FLUOROURACIL REGIMEN FOR NEUTRO AND OR THROMBOPENIA/
Authors: CAPPELAERE P FOURNIER C ROLLAND F MEEUS L DOMENGE C KRAKOWSKI I DEGISLAIN C CHAUVERGNE J DUFOURESQUERRE F PION JM HECQUET B
Citation: P. Cappelaere et al., PREDICTIVE VALUE OF HEMATOLOGICAL COUNTS AT THE 4TH DAY AFTER CARBOPLATIN-FLUOROURACIL REGIMEN FOR NEUTRO AND OR THROMBOPENIA/, Bulletin du cancer, 83(7), 1996, pp. 559-565
CARBOPLATIN AND ETOPOSIDE COMBINATION FOR THE TREATMENT OF RECURRENT EPITHELIAL OVARIAN-CANCER
Authors: CHAUVERGNE J CHINETCHARROT P STOCKLE E THOMAS L TOULOUSE C
Citation: J. Chauvergne et al., CARBOPLATIN AND ETOPOSIDE COMBINATION FOR THE TREATMENT OF RECURRENT EPITHELIAL OVARIAN-CANCER, Bulletin du cancer, 83(4), 1996, pp. 315-323
PHASE-II STUDY OF CYSTEMUSTINE IN ADVANCED HEAD AND NECK-CANCER - A TRIAL OF THE EORTC CLINICAL SCREENING GROUP
Authors: CAPPELAERE P LENTZ MA DEGARDIN M CHAUVERGNE J MAYER F CHOLLET P CHEVALLIER B
Citation: P. Cappelaere et al., PHASE-II STUDY OF CYSTEMUSTINE IN ADVANCED HEAD AND NECK-CANCER - A TRIAL OF THE EORTC CLINICAL SCREENING GROUP, European journal of cancer. Part B, Oral oncology, 31B(2), 1995, pp. 151-152
HIGH-DOSE CHEMOTHERAPY IN ADVANCED OVARIAN-CARCINOMA WITH BULKY RESIDUAL DISEASE
Authors: HERON JF LHOMME C KERBRAT P MAYER F CHEVALLIER B GOUPIL A VENNIN P LEBRUN D CHAUVERGNE J AYME Y NAMER M
Citation: Jf. Heron et al., HIGH-DOSE CHEMOTHERAPY IN ADVANCED OVARIAN-CARCINOMA WITH BULKY RESIDUAL DISEASE, European journal of cancer, 31A, 1995, pp. 503-503
PHASE-II STUDY OF CYSTEMUSTINE IN ADVANCED RENAL-CANCER
Authors: CHAUVERGNE J KERBRAT P ADENIS A CHOLLET P FARGEOT P PUJADELAURAINE E DIERAS V MADELMONT JC LENTZ MA TOULOUSE C CHEVALLIER B
Citation: J. Chauvergne et al., PHASE-II STUDY OF CYSTEMUSTINE IN ADVANCED RENAL-CANCER, European journal of cancer, 31A(1), 1995, pp. 130-131
RANDOMIZED TRIAL OF MYELOPREVENTION BY GORALATINE VS PLACEBO FOR PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA, TREATED BY CARBOPLATIN-FLUOROUROCILE
Authors: CAPPELAERE P HECQUET B ROLLAND F MEEUS L DOMENGE C KRAKOWSKI I DEGISLAIN C CHAUVERGNE J DUFOURESQUERRE F CARDE P
Citation: P. Cappelaere et al., RANDOMIZED TRIAL OF MYELOPREVENTION BY GORALATINE VS PLACEBO FOR PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA, TREATED BY CARBOPLATIN-FLUOROUROCILE, Bulletin du cancer, 82(9), 1995, pp. 732-737
STANDARDS, OPTIONS AND GUIDELINES FOR APP LICATIONS IN CHEMOTHERAPY
Authors: HERON JF FERVERS B LATOUR JF SOMMELET D CHAUVERGNE J PHILIP T
Citation: Jf. Heron et al., STANDARDS, OPTIONS AND GUIDELINES FOR APP LICATIONS IN CHEMOTHERAPY, Bulletin du cancer, 82(10), 1995, pp. 823-834
EVALUATION OF WHOLE ABDOMINAL IRRADIATION IN OVARIAN-CARCINOMA WITH A4 ORTHOGONAL FIELDS TECHNIQUE
Authors: THOMAS L PIGNEUX J CHAUVERGNE J STOCKLE E BUSSIERES E CHEMIN A TOULOUSE C
Citation: L. Thomas et al., EVALUATION OF WHOLE ABDOMINAL IRRADIATION IN OVARIAN-CARCINOMA WITH A4 ORTHOGONAL FIELDS TECHNIQUE, International journal of radiation oncology, biology, physics, 30(5), 1994, pp. 1083-1090
ACUTE ANTIEMETIC EFFICACY AND SAFETY OF DOLASETRON MESYLATE, A 5-HT3 ANTAGONISTS, IN CANCER-PATIENTS TREATED WITH CISPLATIN
Authors: CONROY T CAPPELAERE P FABBRO M FAUSER AA SPLINTER TAW SPIELMANN M SCHNEIDER M CHEVALLIER B GOUPIL A CHAUVERGNE J FARGEOT P PREVOT G OGRADY P GREEN D HARDENBERG J BOYCE M
Citation: T. Conroy et al., ACUTE ANTIEMETIC EFFICACY AND SAFETY OF DOLASETRON MESYLATE, A 5-HT3 ANTAGONISTS, IN CANCER-PATIENTS TREATED WITH CISPLATIN, American journal of clinical oncology, 17(2), 1994, pp. 97-102
PHASE-II TRIAL OF IPROPLATIN IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, ESOPHAGUS AND LUNG
Authors: CAPPELAERE P GUIOCHET N BASTIT P FAVRE R VANDERBURG M GOUPIL A CHAUVERGNE J THOMAS D VANGLABBEKE M ARMAND JP
Citation: P. Cappelaere et al., PHASE-II TRIAL OF IPROPLATIN IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, ESOPHAGUS AND LUNG, European journal of cancer, 29A(8), 1993, pp. 1216-1216
DOES THERE REMAIN A PLACE FOR 2ND-LOOK OP ERATIONS IN THE TREATMENT OF OVARIAN CANCERS
Authors: STOCKLE E BUSSIERES E STOCKLE M AVRIL A THOMAS L CHAUVERGNE J BRUNET R PIGNEUX J MAREE D
Citation: E. Stockle et al., DOES THERE REMAIN A PLACE FOR 2ND-LOOK OP ERATIONS IN THE TREATMENT OF OVARIAN CANCERS, Bulletin du cancer, 80(7), 1993, pp. 629-638
NEOADJUVANT CHEMOTHERAPY FOR STAGES IIB-I II CERVICAL CANCERS - LONG-TERM FOLLOW-UP OF PLURICENTRIC RANDOMIZED STUDY OF 151 PATIENTS
Authors: CHAUVERGNE J LHOMME C ROHART J HERON JF AYME Y GOUPIL A FARGEOT P DAVID M
Citation: J. Chauvergne et al., NEOADJUVANT CHEMOTHERAPY FOR STAGES IIB-I II CERVICAL CANCERS - LONG-TERM FOLLOW-UP OF PLURICENTRIC RANDOMIZED STUDY OF 151 PATIENTS, Bulletin du cancer, 80(12), 1993, pp. 1069-1079
Risultati: 1-16 |